Zydus Cadila

Government will decide on vaccination of children, adolescents on 'scientific rationale', supply situation: Covid Task Force Chief

Zydus Cadila's indigenously developed needle-free COVID-19 vaccine ZyCoV-D is set to become the first vaccine that will be available in India for those in the age group of 12-18 years. 

published on : 17th October 2021

'Lack of vaccine applicators delaying ZyCoV-D launch', say government officials

The Ahmedabad-based company had projected the vaccine as a painless vaccine that has to be administered in three doses.

published on : 12th October 2021

Debate over prices halted launch of Zydus' Covid-19 vaccine on Gandhi Jayanti?

Sources added that a few more rounds of negotiations are likely this week before a government procurement price, as well as price of the vaccine in private hospitals can be fixed.

published on : 5th October 2021

COVID vaccines for kids from November? Final round of talks underway with Zydus Cadila

The Centre is hopeful of a positive outcome from talks with Zydus Cadila, says State Health Minister Dr K Sudhakar while 250 PHCs get upgraded in Karnataka.

published on : 4th October 2021

Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it down

ZyCoV-D has to be differently priced as apart from being a three-dose vaccine, there is a needle-free jet injector used for administering the vaccine.

published on : 3rd October 2021

Kids Covid vaccine: Centre hopeful of positive outcome from talks with Zydus Cadila, says Karnataka Health Minister

He said he also discussed with the Bharat Biotech chief about the status of the nasal vaccine.

published on : 3rd October 2021

Zydus Cadila jab to be rolled out tomorrow

AhmEdabad-based Zydus Cadila’s three-dose Covid-19 vaccine is likely to be included in the national vaccination drive from Saturday, according to Union Health Secretary Rajesh Bhushan.

published on : 1st October 2021

ZyCoV-D to be introduced in Covid vaccination drive shortly: Government

As far as the price at which it will be procured is concerned, Union Health Secretary Rajesh Bhushan told a press conference that the government is in talks with the manufacturer.

published on : 30th September 2021

Zydus Cadila unit gets USFDA nod for generic plaque psoriasis treatment drug

The drug will be manufactured at the Zydus group's formulation manufacturing facility at the special economic zone, Ahmedabad, the drug firm noted.

published on : 24th September 2021

Zydus Cadila gets USFDA nod for schizophrenia treatment drug

Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) and for treatment of schizophrenia.

published on : 9th September 2021

Zydus Cadila vaccine likely to seek 2-dose approval, not 3

The permission granted by DCGI in August was for a three-dose schedule, which was tested for efficacy in the Phase 3 clinical trials.

published on : 4th September 2021

DCGI gives nod for phase 2/3 trials of Biological E's Covid vaccine on those aged between 5 & 18

So far only Zydus Cadila's needle-free COVID-19 vaccine ZyCoV-D has received Emergency Use Authorisation to be administered in the age group of under 18 years in the country.

published on : 1st September 2021

Zydus Cadila's COVID-19 vaccine to be available from first week of October

Further, a decision on whether all children or only those with co-morbidities will be administered the COVID-19 vaccine on priority has not yet been taken, the government said on Thursday.

published on : 27th August 2021

NTAGI to soon chalk out roadmap to introduce Zydus Cadila's vaccine in Covid inoculation drive

Dr N K Arora said it is estimated that there are around 12 crore adolescents in the age group of 12-18 years in India and less than 1 per cent of them may have comorbidities.

published on : 25th August 2021

Despite approval to Zydus Cadila vaccine, kids' inoculation may not start anytime soon

Vaccination for adolescents and kids with serious comorbidities, however, are likely to start in October when sufficient doses of ZyCoV D is available.

published on : 25th August 2021
1 2 3 >